- $273.10m
- $301.76m
- $131.29m
- 93
- 72
- 34
- 73
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 114 | 118 | 124 | 129 | 131 |
Cost of Revenue | |||||
Gross Profit | 66.4 | 66.2 | 69.9 | 70.1 | 69.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 85.1 | 87.8 | 85.3 | 95.1 | 106 |
Operating Profit | 29 | 30.1 | 38.9 | 34 | 25.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 33.9 | 34.1 | 51.1 | 33.8 | 25.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.4 | 26.4 | 37.3 | 24.8 | 17.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 25.8 | 26.2 | 37.3 | 24.8 | 17.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 25.8 | 26.2 | 37.3 | 24.8 | 17.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1,254 | 1,352 | 1,847 | 1,368 | 1,236 |